NEXUS AG (NXU.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:NXU - DE0005220909 - Common Stock
71.2 EUR
-0.1 (-0.14%)
Taking everything into account, NXU scores 6 out of 10 in our fundamental rating. NXU was compared to 11 industry peers in the Health Care Technology industry. NXU has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NXU is valued quite expensively, but it does show have an excellent growth rating. These ratings could make NXU a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
NXU had positive earnings in the past year.
In the past year NXU had a positive cash flow from operations.
Each year in the past 5 years NXU has been profitable.
NXU had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
NXU has a Return On Assets (6.93%) which is in line with its industry peers.
The Return On Equity of NXU (11.27%) is better than 63.64% of its industry peers.
NXU's Return On Invested Capital of 8.35% is in line compared to the rest of the industry. NXU outperforms 54.55% of its industry peers.
NXU had an Average Return On Invested Capital over the past 3 years of 7.85%. This is in line with the industry average of 9.28%.
The last Return On Invested Capital (8.35%) for NXU is above the 3 year average (7.85%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.93% | ||
| ROE | 11.27% | ||
| ROIC | 8.35% |
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
1.3 Margins
NXU's Profit Margin of 12.11% is fine compared to the rest of the industry. NXU outperforms 72.73% of its industry peers.
NXU's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 15.41%, NXU is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
NXU's Operating Margin has improved in the last couple of years.
NXU has a better Gross Margin (84.70%) than 72.73% of its industry peers.
In the last couple of years the Gross Margin of NXU has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.41% | ||
| PM (TTM) | 12.11% | ||
| GM | 84.7% |
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NXU is creating some value.
Compared to 1 year ago, NXU has about the same amount of shares outstanding.
The number of shares outstanding for NXU has been increased compared to 5 years ago.
NXU has a better debt/assets ratio than last year.
2.2 Solvency
NXU has an Altman-Z score of 5.57. This indicates that NXU is financially healthy and has little risk of bankruptcy at the moment.
NXU has a Altman-Z score of 5.57. This is amongst the best in the industry. NXU outperforms 90.91% of its industry peers.
NXU has a debt to FCF ratio of 0.34. This is a very positive value and a sign of high solvency as it would only need 0.34 years to pay back of all of its debts.
NXU has a Debt to FCF ratio of 0.34. This is in the better half of the industry: NXU outperforms 72.73% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that NXU is not too dependend on debt financing.
NXU has a better Debt to Equity ratio (0.05) than 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.34 | ||
| Altman-Z | 5.57 |
ROIC/WACC1.16
WACC7.21%
2.3 Liquidity
A Current Ratio of 2.13 indicates that NXU has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.13, NXU is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
NXU has a Quick Ratio of 2.08. This indicates that NXU is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.08, NXU is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.08 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.97% over the past year.
The Earnings Per Share has been growing by 20.97% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 7.41% in the past year.
NXU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.11% yearly.
EPS 1Y (TTM)26.97%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%-3.19%
Revenue 1Y (TTM)7.41%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%9.14%
3.2 Future
Based on estimates for the next years, NXU will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.50% on average per year.
NXU is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.47% yearly.
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
NXU is valuated quite expensively with a Price/Earnings ratio of 36.14.
NXU's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of NXU to the average of the S&P500 Index (27.17), we can say NXU is valued slightly more expensively.
The Price/Forward Earnings ratio is 32.24, which means the current valuation is very expensive for NXU.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NXU is on the same level as its industry peers.
NXU is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.79, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.14 | ||
| Fwd PE | 32.24 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NXU is valued a bit more expensive than the industry average as 63.64% of the companies are valued more cheaply.
63.64% of the companies in the same industry are more expensive than NXU, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.76 | ||
| EV/EBITDA | 16.21 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NXU does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of NXU may justify a higher PE ratio.
A more expensive valuation may be justified as NXU's earnings are expected to grow with 15.50% in the coming years.
PEG (NY)2.48
PEG (5Y)1.72
EPS Next 2Y14.95%
EPS Next 3Y15.5%
5. Dividend
5.1 Amount
NXU has a yearly dividend return of 0.32%, which is pretty low.
Compared to an average industry Dividend Yield of 2.25, NXU has a dividend in line with its industry peers.
With a Dividend Yield of 0.32, NXU pays less dividend than the S&P500 average, which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
5.2 History
The dividend of NXU has a limited annual growth rate of 2.17%.
Dividend Growth(5Y)2.17%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
NXU pays out 11.69% of its income as dividend. This is a sustainable payout ratio.
NXU's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP11.69%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
FRA:NXU (11/24/2025, 7:00:00 PM)
71.2
-0.1 (-0.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners21.55%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.23B
Revenue(TTM)280.33M
Net Income(TTM)33.95M
Analysts45.71
Price Target71.4 (0.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
Yearly Dividend0.22
Dividend Growth(5Y)2.17%
DP11.69%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.14 | ||
| Fwd PE | 32.24 | ||
| P/S | 4.39 | ||
| P/FCF | 21.76 | ||
| P/OCF | 18.33 | ||
| P/B | 4.08 | ||
| P/tB | 17.79 | ||
| EV/EBITDA | 16.21 |
EPS(TTM)1.97
EY2.77%
EPS(NY)2.21
Fwd EY3.1%
FCF(TTM)3.27
FCFY4.59%
OCF(TTM)3.88
OCFY5.46%
SpS16.23
BVpS17.45
TBVpS4
PEG (NY)2.48
PEG (5Y)1.72
Graham Number27.81
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.93% | ||
| ROE | 11.27% | ||
| ROCE | 11.14% | ||
| ROIC | 8.35% | ||
| ROICexc | 12.84% | ||
| ROICexgc | 162.09% | ||
| OM | 15.41% | ||
| PM (TTM) | 12.11% | ||
| GM | 84.7% | ||
| FCFM | 20.15% |
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
ROICexc(3y)12.19%
ROICexc(5y)11.45%
ROICexgc(3y)147.03%
ROICexgc(5y)150.84%
ROCE(3y)10.47%
ROCE(5y)10.94%
ROICexgc growth 3Y-0.23%
ROICexgc growth 5Y4.33%
ROICexc growth 3Y3.77%
ROICexc growth 5Y2.6%
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
F-Score6
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.34 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 53.69% | ||
| Cap/Sales | 3.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 106.6% | ||
| Profit Quality | 166.39% | ||
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.08 | ||
| Altman-Z | 5.57 |
F-Score6
WACC7.21%
ROIC/WACC1.16
Cap/Depr(3y)46.55%
Cap/Depr(5y)41.01%
Cap/Sales(3y)3.52%
Cap/Sales(5y)3.36%
Profit Quality(3y)122.34%
Profit Quality(5y)137.83%
High Growth Momentum
Growth
EPS 1Y (TTM)26.97%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%-3.19%
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.41%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%9.14%
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
EBIT growth 1Y16.23%
EBIT growth 3Y16.4%
EBIT growth 5Y15.93%
EBIT Next Year66.24%
EBIT Next 3Y29.63%
EBIT Next 5YN/A
FCF growth 1Y141.55%
FCF growth 3Y16.82%
FCF growth 5Y17.03%
OCF growth 1Y109.22%
OCF growth 3Y17.98%
OCF growth 5Y15.93%
NEXUS AG / NXU.DE FAQ
Can you provide the ChartMill fundamental rating for NEXUS AG?
ChartMill assigns a fundamental rating of 7 / 10 to NXU.DE.
What is the valuation status for NXU stock?
ChartMill assigns a valuation rating of 3 / 10 to NEXUS AG (NXU.DE). This can be considered as Overvalued.
Can you provide the profitability details for NEXUS AG?
NEXUS AG (NXU.DE) has a profitability rating of 7 / 10.
How financially healthy is NEXUS AG?
The financial health rating of NEXUS AG (NXU.DE) is 8 / 10.
What is the expected EPS growth for NEXUS AG (NXU.DE) stock?
The Earnings per Share (EPS) of NEXUS AG (NXU.DE) is expected to grow by 14.6% in the next year.